SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t

Infection of the CNS with the SARS-CoV-2 can occur via different routes and results in para- or post-infectious manifestations with a variety of neurological symptoms. In patients with neurodegenerative diseases, SARS-CoV-2 is often associated with a higher fatality rate, which is a relevant problem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingor, Paul, Demleitner, Antonia F., Wolff, Andreas W., Feneberg, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013492/
https://www.ncbi.nlm.nih.gov/pubmed/35434769
http://dx.doi.org/10.1007/s00702-022-02500-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013492/
https://www.ncbi.nlm.nih.gov/pubmed/35434769
http://dx.doi.org/10.1007/s00702-022-02500-w

Ejemplares similares